- Lobbying
- Lobbying by Mallinckrodt LLC
Lobbying Relationship
Bills mentioned
H.R.1319: American Rescue Plan Act of 2021
Sponsor: John Yarmuth (D-Ky.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Erika Long | Legislative Asst, Rep Jim Davis; Sr Legislative Asst, Rep Bart Stupak; Professional Staff, Energy & Commerce Committee; Sr Investigator, US Senate Committee on the Judiciary Legislative Asst, Rep. Jim Davis; Sr. Legislative Asst, Rep Bart Stupak; Professional Staff, Energy & Commerce Committee; Sr. Investigator, US Senate Committee on the Judiciary |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Amendment
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Amendment
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Medicare
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Registration
Issue(s) they said they’d lobby about: Issues related to opioid abuse and alternatives to opioids, issues related to Medicare Part D..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate